Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Mixer cell, modulator and method
Modeling propulsion-related interfaces in computational fluid dynamics
Apparatus and method for synchronizing robots
Upstream channel bonding using legacy maps in a cable communications system
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
Sharing keys between cooperating parties
System and method for inferring user interest based on analysis of user-generated metadata
  Randomly Featured Patents
Muffler for internal combustion engines
Portable electronic computer
Nail buffer
Hose and linkage support apparatus for a sump vehicle
Toy bench with vise
Bath tub for invalids
Valve handle
Alkali-resistant glass composition
Infusion status indicator